跳至主要内容
临床试验/NCT03655457
NCT03655457Unknown不适用

Evaluation of the Efficacy of Different Surfactant Preparations in Preterm Infants by Lung Ultrasound

Zekai Tahir Burak Women's Health Research and Education Hospital1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2018年3月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
64
试验地点
1
主要终点
Lung usg scores

研究概览

简要总结

To compare the lung ultrasound scores after two different natural surfactant administration as a parameter reflecting lung inflation. Poractant alfa decreases lung ultrasound scores as efficient as beractant treatment

详细描述

Outcomes:

Improvement of Lung usg scores after surfactanct and the difference between groups at different time points (2nd and 6hr).

Secondary outcome:

The correlation between lung usg scores and clinical scores (silverman scores), FiO2 and PCO2 levels, failure of weaning to noninvasive ventilation after surfactant Preterm infants of 32 gestational weeks and below, who admit to the NICU with signs of respiratory distress, treated with non invasive or mechanical ventilation and require surfactant treatment in 6 hours of life will be enrolled.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
1 Hour 至 6 Hours(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Preterm infants of 32 gestational weeks and below, who admit to the NICU with signs of respiratory distress, treated with non invasive or mechanical ventilation and require surfactant treatment in 6 hours of life will be enrolled.

排除标准

  • •major congenital anomalies.

研究组 & 干预措施

group 1 Poractant alfa

Experimental

Poractant alfa generic name: curosurf 120 and 240 mg flk dosage: 200 mg/ kg intratracheal application frequency and duration: in the first two hours

干预措施: group 1 Poractant alfa (Device)

group 2 beractant

Active Comparator

beractant generic name: survanta 8 cc flk dosage: 4 cc/ kg intratracheal application frequency and duration: in the first two hours

干预措施: group 2 beractant (Device)

结局指标

主要结局

Lung usg scores

时间窗: first days

Evaluation of Lung Usg Scores in infants treated with surfactant in the first six hours (Brat lung usg scores). Each item scored 0-3. (0 indicates A-pattern (defined by the presence of the only A-lines); 1, B-pattern (defined as the presence of ≥3 well-spaced B-lines); 2, severe B-pattern (defined as the presence of crowded and coalescent B-lines with or without consolidations limited to the subpleural space); and 3, extended consolidations.) - Higher values represent a worse outcome

次要结局

未报告次要终点

研究者

发起方
Zekai Tahir Burak Women's Health Research and Education Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验